Gastrointestinal varices primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Primary prevention of variceal bleeding may be achieved via rigorous surveillance of varices after their development and via the use non-selective beta blockers and/or endoscopic band ligation (EBL). Liver disease is the most common cause of portal hypertension and effective measures for the [[primary prevention]] of [[liver diseases]] include [[hepatitis B]] [[vaccination]], avoidance from [[Unprotected sex|unprotected sexual intercourse]], precise [[screening]] of the [[Blood product|blood products]] before infusion, reducing [[alcohol consumption]], [[obesity]] prevention, and [[diabetes mellitus]] prevention. | Primary prevention of variceal bleeding may be achieved via rigorous surveillance of varices after their development and via the use [[Beta blockers|non-selective beta blockers]] and/or endoscopic band ligation (EBL). Liver disease is the most common cause of [[portal hypertension]] and effective measures for the [[primary prevention]] of [[liver diseases]] include [[hepatitis B]] [[vaccination]], avoidance from [[Unprotected sex|unprotected sexual intercourse]], precise [[screening]] of the [[Blood product|blood products]] before infusion, reducing [[alcohol consumption]], [[obesity]] prevention, and [[diabetes mellitus]] prevention. | ||
==Primary Prevention== | ==Primary Prevention== | ||
Effective measures to [[Prevention (medical)|prevent]] variceal bleeding include the following:<ref name="pmid25018847">{{cite journal |vauthors=Triantos C, Kalafateli M |title=Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis |journal=World J Hepatol |volume=6 |issue=6 |pages=363–9 |year=2014 |pmid=25018847 |pmc=4081611 |doi=10.4254/wjh.v6.i6.363 |url=}}</ref> | |||
'''Cirrhosis''' | '''Cirrhosis''' | ||
*Diagnostic endoscopy for the presence of varices | *Diagnostic [[endoscopy]] for the presence of varices | ||
'''No varices''' | '''No varices''' | ||
*Surveillance for development of varices (every 2-3 yr in compensated cirrhosis/yearly in cases of decompensation) | *Surveillance for development of varices (every 2-3 yr in compensated [[cirrhosis]]/yearly in cases of decompensation) | ||
'''Small varices-low bleeding risk''' | '''Small varices-low bleeding risk''' | ||
*Surveillance for progression of varices (every 1-2 yr in compensated cirrhosis/yearly in cases of decompensation) | *Surveillance for progression of varices (every 1-2 yr in compensated [[cirrhosis]]/yearly in cases of decompensation) | ||
'''Small varices-high bleeding risk''' | '''Small varices-high bleeding risk''' | ||
*Non-selective beta blockers | *[[Beta blockers|Non-selective beta blockers]] | ||
'''Medium-large varices''' | '''Medium-large varices''' | ||
*Non-selective beta blockers or endoscopic band ligation (EBL) | *[[Beta blockers|Non-selective beta blockers]] or endoscopic band ligation (EBL) | ||
'''Prevention of liver disease''' | |||
* Effective measures for the [[primary prevention]] of [[liver diseases]], as the main causes of portal hypertension, include:<ref name="pmid21877109">{{cite journal |vauthors=Flores YN, Lang CM, Salmerón J, Bastani R |title=Risk factors for liver disease and associated knowledge and practices among Mexican adults in the US and Mexico |journal=J Community Health |volume=37 |issue=2 |pages=403–11 |year=2012 |pmid=21877109 |doi=10.1007/s10900-011-9457-4 |url=}}</ref> | * Effective measures for the [[primary prevention]] of [[liver diseases]], as the main causes of portal hypertension, include:<ref name="pmid21877109">{{cite journal |vauthors=Flores YN, Lang CM, Salmerón J, Bastani R |title=Risk factors for liver disease and associated knowledge and practices among Mexican adults in the US and Mexico |journal=J Community Health |volume=37 |issue=2 |pages=403–11 |year=2012 |pmid=21877109 |doi=10.1007/s10900-011-9457-4 |url=}}</ref> | ||
** Prevention of [[hepatitis B]] through [[vaccination]] | ** Prevention of [[hepatitis B]] through [[vaccination]] | ||
Latest revision as of 04:39, 8 January 2018
|
Gastrointestinal varices Microchapters |
|
Differentiating Gastrointestinal varices from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Gastrointestinal varices primary prevention On the Web |
|
American Roentgen Ray Society Images of Gastrointestinal varices primary prevention |
|
Risk calculators and risk factors for Gastrointestinal varices primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]
Overview
Primary prevention of variceal bleeding may be achieved via rigorous surveillance of varices after their development and via the use non-selective beta blockers and/or endoscopic band ligation (EBL). Liver disease is the most common cause of portal hypertension and effective measures for the primary prevention of liver diseases include hepatitis B vaccination, avoidance from unprotected sexual intercourse, precise screening of the blood products before infusion, reducing alcohol consumption, obesity prevention, and diabetes mellitus prevention.
Primary Prevention
Effective measures to prevent variceal bleeding include the following:[1]
Cirrhosis
- Diagnostic endoscopy for the presence of varices
No varices
- Surveillance for development of varices (every 2-3 yr in compensated cirrhosis/yearly in cases of decompensation)
Small varices-low bleeding risk
- Surveillance for progression of varices (every 1-2 yr in compensated cirrhosis/yearly in cases of decompensation)
Small varices-high bleeding risk
Medium-large varices
- Non-selective beta blockers or endoscopic band ligation (EBL)
Prevention of liver disease
- Effective measures for the primary prevention of liver diseases, as the main causes of portal hypertension, include:[2]
- Prevention of hepatitis B through vaccination
- Avoid unprotected sexual intercourse
- Prevention of hepatitis C through precise screening of the blood products before infusion
- Reduction of alcohol consumption
- Prevention of overweight and obesity
- Prevention of diabetes mellitus
References
- ↑ Triantos C, Kalafateli M (2014). "Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis". World J Hepatol. 6 (6): 363–9. doi:10.4254/wjh.v6.i6.363. PMC 4081611. PMID 25018847.
- ↑ Flores YN, Lang CM, Salmerón J, Bastani R (2012). "Risk factors for liver disease and associated knowledge and practices among Mexican adults in the US and Mexico". J Community Health. 37 (2): 403–11. doi:10.1007/s10900-011-9457-4. PMID 21877109.